MD678G2 - DI-(mu-O)-di[N-(2-oxo-1-naphtal)-N'-alpha-oxobenzalhydrazinecopper] dihydrate manifesting selective antimicrobic properties - Google Patents
DI-(mu-O)-di[N-(2-oxo-1-naphtal)-N'-alpha-oxobenzalhydrazinecopper] dihydrate manifesting selective antimicrobic propertiesInfo
- Publication number
- MD678G2 MD678G2 MD96-0167A MD960167A MD678G2 MD 678 G2 MD678 G2 MD 678G2 MD 960167 A MD960167 A MD 960167A MD 678 G2 MD678 G2 MD 678G2
- Authority
- MD
- Moldova
- Prior art keywords
- selective
- oxobenzalhydrazinecopper
- dihydrate
- oxo
- antimicrobic
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to the new biological active substances from the class of the co-ordinative combinations of the transitional metalls with hydrazones, and can be applied in medicine and in microbiology in the creation of the nutritive selective media.The summary of the invention consists in receiving a new biological active co-ordinative combination, in particular di(µ-O)- di[N-(2-oxo-1-naphthal)-N'-α-oxobenzalhydrazinecopper] dihydrate, which possesses selective antimicrobic activities.The technical result of the invention consists in the fact, that the antimicrobic activity of the proposed complex concerning the Staphylococcus bacteria is increasing in comparison with its prototype non less than 129 times, but to the Escherihia (intestinal) bacilli is remaining at the same level.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MD96-0167A MD678G2 (en) | 1996-07-17 | 1996-07-17 | DI-(mu-O)-di[N-(2-oxo-1-naphtal)-N'-alpha-oxobenzalhydrazinecopper] dihydrate manifesting selective antimicrobic properties |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MD96-0167A MD678G2 (en) | 1996-07-17 | 1996-07-17 | DI-(mu-O)-di[N-(2-oxo-1-naphtal)-N'-alpha-oxobenzalhydrazinecopper] dihydrate manifesting selective antimicrobic properties |
Publications (2)
Publication Number | Publication Date |
---|---|
MD678F1 MD678F1 (en) | 1997-02-28 |
MD678G2 true MD678G2 (en) | 1997-09-30 |
Family
ID=19738875
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MD96-0167A MD678G2 (en) | 1996-07-17 | 1996-07-17 | DI-(mu-O)-di[N-(2-oxo-1-naphtal)-N'-alpha-oxobenzalhydrazinecopper] dihydrate manifesting selective antimicrobic properties |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD678G2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD4174C1 (en) * | 2011-10-25 | 2013-01-31 | Институт Химии Академии Наук Молдовы | Thiosemicarbazone derivatives of 4-formyl-3-hydroxy-2-naphthoic acid with antibacterial properties |
-
1996
- 1996-07-17 MD MD96-0167A patent/MD678G2/en active IP Right Grant
Non-Patent Citations (2)
Title |
---|
М.Д.Машковский. "Лекарственные средства", т. 2, 1987 г.,"Беларусь", Минск, с. 264-265. * |
Таркоджиель Мианперем. "Координационные соединения 3d-элементов с некоторыми гидразонами и азинами". 1991 г., Дис. канд. хим. наук, Кишинев, с.163. * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD4174C1 (en) * | 2011-10-25 | 2013-01-31 | Институт Химии Академии Наук Молдовы | Thiosemicarbazone derivatives of 4-formyl-3-hydroxy-2-naphthoic acid with antibacterial properties |
Also Published As
Publication number | Publication date |
---|---|
MD678F1 (en) | 1997-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2132369A1 (en) | Use for the Treatment of Mixed Skins, of an Effective Quantity of Active Substances | |
AU3506893A (en) | Use of fullerenes in diagnostic and/or therapeutic agents | |
DK1005353T3 (en) | A pharmaceutical composition comprising Lactobacillus casei rhamnosus | |
ZA895936B (en) | Pharmaceutical compositions comprising selected lactobacillus strains | |
ATE166105T1 (en) | BACILLUS BACTERIA AND ITS USE | |
HUP0100786A3 (en) | Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them | |
ATE207755T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING LACTOBACILLUS BREVIS AND LACTOBACILLUS SALIVARIUS FOR THE TREATMENT OF VAGINAL INFECTIONS | |
ATE107660T1 (en) | THERAPEUTIC AGENT. | |
HU9401260D0 (en) | Fema gene of staphylococcus epidermis, fema protein, and vectors and microorganisms comprising the fema gene | |
WO1997040072A3 (en) | Adam proteins and uses thereof | |
IL84092A0 (en) | Glycopeptidic antibiotics | |
FR2703995B1 (en) | 5-ACYLAMINO 1,2,4-THIADIAZOLES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
MD678G2 (en) | DI-(mu-O)-di[N-(2-oxo-1-naphtal)-N'-alpha-oxobenzalhydrazinecopper] dihydrate manifesting selective antimicrobic properties | |
GB9424661D0 (en) | Enzymes, microorganisms and their use | |
DE59808313D1 (en) | USE OF COMBINATIONS OF ACTIVE SUBSTANCES FROM ANTIBIOTICS AND TERPENIC PLANT EXTRACTS IN ANIMAL MEDICINE | |
TW365538B (en) | Pharmaceutical composition for preventing a bacterial disease of fishes and crustaceans | |
CA2140012A1 (en) | Anxiolytic | |
Hamann | Enhancement of tyrosinase stability by immobilization on nylon 66 | |
ATE188485T1 (en) | NEW PEPTIDIC ACTIVE INGREDIENT AND ITS PRODUCTION | |
WO2000064417A3 (en) | Inactivated microorganisms comprising substances having pharmacological activity | |
Cotton | Atovaquone (Mepron) suspension approved by FDA. Food and Drug Administration | |
DE69830371D1 (en) | Inactivated microorganisms containing minerals, their preparation and use in food, pharmaceutical and zootechnical compositions | |
OA09771A (en) | Asphodelus composition for increasing white blood cell count. | |
GB2172704B (en) | Antigenically active protein and its use in the diagnosis of gonorrhoea | |
Kieffer | Cosmetic surgery of the aging face: social, psychological, and ethical implications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG3A | Granted patent for invention | ||
IF99 | Valid patent on 19990615 |
Free format text: EXPIRES: 20160717 |